News

21.04.2016

World MS Day 2016: EMSP independence Twitter chats

In the run-up to World Multiple Sclerosis (MS) Day, EMSP held three Twitter chats focused on the main aspects of achieving independence…

World MS Day 2016: EMSP independence Twitter chats

21.04.2016

In the run-up to World Multiple Sclerosis (MS) Day, EMSP held three Twitter chats focused on the main aspects of achieving independence while living with multiple sclerosis.

EMA and EUnetHTA release joint report on medicines data

15.04.2016

The European Medicines Agency (EMA) and the European Network for Health Technology Assessment (EUnetHTA) have published a report on their…

15.04.2016

EMA and EUnetHTA release joint report on medicines data

The European Medicines Agency (EMA) and the European Network for Health Technology Assessment (EUnetHTA) have published a report on their joint work plan on the generation of data on medicines, pre- and post-authorisation.

Republic of Moldova: only 35 out of 1,000 MS patients receive reimbursed treatment

07.04.2016

The MS Society in the Republic of Moldova (MSSM) organised a national roundtable debate on the topic of rehabilitation of…

Republic of Moldova: only 35 out of 1,000 MS patients receive reimbursed treatment

07.04.2016

The MS Society in the Republic of Moldova (MSSM) organised a national roundtable debate on the topic of rehabilitation of…

04.04.2016

Ready for Work social media campaign: 140,000 people reached

EMSP thanks all its partners and supporters who contributed to our successful social media ‘Thunderclap’ campaign around our new Ready…

Ready for Work social media campaign: 140,000 people reached

04.04.2016

EMSP thanks all its partners and supporters who contributed to our successful social media ‘Thunderclap’ campaign around our new Ready…

European Medicines Agency: Treatment Updates

30.03.2016

The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU). The Agency is responsible for the scientific evaluation, supervision and safety monitoring of medicines developed by pharmaceutical companies for use in the EU.

1 44 45 46 47 48 67